VANGUARD GROUP INC 13D and 13G filings for Rigel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:13 pm Sale |
2023-12-29 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
VANGUARD GROUP INC | 895,322 5.130% |
-313,058 (-25.91%) |
Filing |
| 2023-02-09 11:30 am Purchase |
2022-12-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
VANGUARD GROUP INC | 1,208,380 6.990% |
305,568 (+33.85%) |
Filing |
| 2022-02-10 08:32 am Sale |
2021-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
VANGUARD GROUP INC | 902,811 5.280% |
-11,749 (-1.28%) |
Filing |
| 2021-02-10 11:51 am Purchase |
2020-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
VANGUARD GROUP INC | 914,560 5.410% |
31,036 (+3.51%) |
Filing |